About IRIDEX Corporation
https://www.iridex.comIRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology.
CEO
Patrick Mercer
Compensation Summary
(Year 2024)
ETFs Holding This Stock
Summary
Showing Top 1 of 11
Ratings Snapshot
Rating : C+
Price Target
Institutional Ownership
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE
Shares:1M
Value:$1.32M
PARAGON ASSOCIATES II, LTD
Shares:925K
Value:$1.22M
VANGUARD GROUP INC
Shares:578.71K
Value:$763.9K
Summary
Showing Top 3 of 32
About IRIDEX Corporation
https://www.iridex.comIRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $12.48M ▼ | $5.42M ▼ | $-1.57M ▼ | -12.6% ▼ | $-0.09 ▼ | $-1.2M ▼ |
| Q2-2025 | $13.57M ▲ | $5.54M ▲ | $-994K ▲ | -7.32% ▲ | $-0.06 ▲ | $-595K ▲ |
| Q1-2025 | $11.9M ▼ | $5.26M ▼ | $-1.69M ▼ | -14.17% ▼ | $-0.1 ▼ | $-1.29M ▼ |
| Q4-2024 | $12.7M ▲ | $6.09M ▼ | $-834K ▲ | -6.57% ▲ | $-0.05 ▲ | $-125K ▲ |
| Q3-2024 | $11.58M | $6.19M | $-1.93M | -16.69% | $-0.12 | $-1.59M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $5.57M ▼ | $28.35M ▼ | $23.67M ▼ | $4.68M ▼ |
| Q2-2025 | $6.78M ▼ | $31.59M ▼ | $25.53M ▼ | $6.06M ▲ |
| Q1-2025 | $7.24M ▲ | $34.24M ▲ | $33.38M ▲ | $852K ▼ |
| Q4-2024 | $2.39M ▼ | $29.14M ▼ | $27.04M ▼ | $2.1M ▼ |
| Q3-2024 | $3.86M | $30.15M | $27.53M | $2.62M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-1.57M ▼ | $0 ▲ | $0 ▲ | $0 ▲ | $-1.21M ▼ | $0 ▲ |
| Q2-2025 | $-994K ▲ | $-397K ▲ | $-13K ▼ | $-14K ▼ | $-466K ▼ | $-410K ▲ |
| Q1-2025 | $-1.69M ▼ | $-1.15M ▲ | $-11K ▼ | $6.04M ▲ | $4.86M ▲ | $-1.16M ▲ |
| Q4-2024 | $-834K ▲ | $-1.24M ▲ | $-9K ▼ | $-218K ▼ | $-1.47M ▼ | $-1.25M ▲ |
| Q3-2024 | $-1.93M | $-3.07M | $-1K | $2.82M | $-251K | $-3.07M |
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
 Cyclo G Six | $10.00M ▲ | $0 ▼ | $0 ▲ | $0 ▲ |
 Product and Service Other | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
 Retina | $10.00M ▲ | $10.00M ▲ | $10.00M ▲ | $10.00M ▲ |
Revenue by Geography
| Region | Q4-2024 | Q3-2025 | Q1-2025 | Q2-2025 |
|---|---|---|---|---|
 Americas excluding US | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
 Asia Pacific | $10.00M ▲ | $0 ▼ | $0 ▲ | $0 ▲ |
 Europe Middle East And Africa | $10.00M ▲ | $0 ▼ | $0 ▲ | $0 ▲ |
 UNITED STATES | $10.00M ▲ | $10.00M ▲ | $10.00M ▲ | $10.00M ▲ |
CEO
Patrick Mercer
Compensation Summary
(Year 2024)
ETFs Holding This Stock
Summary
Showing Top 1 of 11
Ratings Snapshot
Rating : C+
Price Target
Institutional Ownership
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE
Shares:1M
Value:$1.32M
PARAGON ASSOCIATES II, LTD
Shares:925K
Value:$1.22M
VANGUARD GROUP INC
Shares:578.71K
Value:$763.9K
Summary
Showing Top 3 of 32